PATENT CLAIM ANALYSIS

Application Number: 15937358
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["705", "044000"]

Abstract:
A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.

Claim (Index 1):
A mobile device comprising:\n one or more biometric sensors configured to acquire a physiological marker from which a user is identifiable and thereby authenticated; a short-range communication interface configured to implement short-range communication technology and enable contactless payment capability of the mobile device; and a processor coupled to the one or more biometric sensors and short-range communication interface, and programmed to at least:\n cause the one or more biometric sensors to acquire the physiological marker, and identify and authenticate the user based thereon; \n send a message to an authentication server that indicates the user is authenticated, and receive a response from the authentication server that includes a unique authentication code; \n receive selection of a thereby selected over-the-counter (OTC) drug; and \n communicate with a point-of-sale (POS) system with contactless payment capability, to purchase the selected OTC drug using the short-range communication interface and the contactless payment capabilities of the mobile device and POS system, \n wherein the processor being programmed to communicate with the POS system includes being programmed to send a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information, the POS system being configured to communicate with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 2.54688
- Patent Class: 705.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12414323', '13331801', '13418196', '12339850', '13794025']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.1111037954412898
- 35 USC 102 Novelty (BERT): 0.4769792182089371
- Combined Prediction Score: 0.1476913377180545
- Mean Citation Score: 195.621922
- Max Citation Score: 218.31635
- Similarity Product: 176.4795537645161

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test